Guide
The complete US patient's guide to stem cell therapy in Medellín
What to expect from consultation to recovery — flights, cost, protocols, and aftercare.
Read article →
Evidence-Based Regenerative Medicine
The Science Behind Your Healing
Every Colombia Care protocol is grounded in published clinical research, INVIMA-regulated methodology, and certified cell science. Here's how mesenchymal stem cells work — and why our approach delivers real results.
Research & Regulatory Partners
01 — The Science
What are mesenchymal stem cells?
Mesenchymal stem cells (MSCs) are multipotent adult cells found in umbilical cord tissue, bone marrow, and adipose tissue. Unlike embryonic stem cells, MSCs are ethically sourced and carry no controversial associations. They're the foundation of modern regenerative medicine.
MSCs have four capabilities that make them powerful therapeutic tools:
- Differentiation — MSCs develop into bone, cartilage, muscle, tendon, and fat cells, directly replacing damaged tissue
- Paracrine signaling — They release growth factors, cytokines, and exosomes that recruit your body's own repair cells to the injury site
- Immunomodulation — MSCs regulate inflammation, calming overactive immune responses that cause chronic pain and tissue degeneration
- Anti-fibrotic effects — They reduce scar tissue formation, promoting healthier, more functional tissue repair
In simple terms: MSCs don't just mask symptoms. They address the underlying damage — reducing inflammation, stimulating tissue regeneration, and restoring function at the cellular level.
02 — Regulation
INVIMA: Colombia's FDA equivalent.
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) is Colombia's national regulatory authority for medicines, medical devices, and biological products. It functions like the US FDA or Europe's EMA — overseeing clinical standards, facility inspections, and product safety across the country.
INVIMA regulates every aspect of our practice: the stem cell products we use, the laboratory that processes them, the facilities where treatments are administered, and the clinical protocols our physicians follow. Non-compliance carries severe penalties, including facility closure.
- Government oversight of all biological products and medical procedures
- Facility inspections and licensing requirements
- Same regulatory framework as Colombia's hospitals and pharmaceutical industry
- Your treatment is a medical procedure under enforced clinical standards — not a wellness experiment
03 — Our Laboratory
Innocell: GMP-certified cell processing.
Colombia Care partners exclusively with Innocell — Colombia's leading stem cell laboratory. Innocell operates under GMP (Good Manufacturing Practice) certification, the international gold standard for pharmaceutical and biological product manufacturing.
Every batch of mesenchymal stem cells used in our protocols is processed, tested, and documented by Innocell's team of cell biologists. This is a clinical partnership that ensures consistency, traceability, and quality at every step.
- GMP-certified processing facility
- Cell viability testing on every batch (minimum 95% viability threshold)
- Sterility and endotoxin testing per international standards
- Full chain-of-custody documentation from donor to patient
- Ethically sourced umbilical cord tissue (Wharton's jelly)
- Screened, healthy donors from full-term pregnancies
Published research supporting MSC therapy.
Below are peer-reviewed studies and meta-analyses relevant to the protocols we offer. Links open directly on PubMed / NIH.
01
Orthopedic & Joint Regeneration
Randomized controlled trials show MSC injections significantly improve pain, cartilage thickness, and functional outcomes in knee osteoarthritis — outperforming hyaluronic acid and corticosteroid injections at 12-month follow-up.
Meta-analysis — Stem Cell Research & Therapy (2020) →
RCT — MSC vs. HA for knee OA, Am J Sports Med (2019) →
02
Spinal & Disc Conditions
Intradiscal MSC injections can reduce disc degeneration, restore disc height, and provide sustained pain relief at 24+ months. Phase II trials demonstrate meaningful improvement in patients with degenerative disc disease.
Phase II trial — Intradiscal MSCs, The Spine Journal (2017) →
Systematic review — MSC therapy for DDD, Pain Physician (2018) →
03
Chronic Pain & Inflammation
MSC therapy demonstrates immunomodulatory effects — reducing systemic inflammation and providing sustained relief in conditions like fibromyalgia, neuropathic pain, and CRPS where conventional treatments have failed.
Review — MSC immunomodulation, J Clinical Medicine (2021) →
Systematic review — MSCs for neuropathic pain, Pain Medicine (2022) →
04
Aesthetic & Hair Restoration
MSC-derived growth factors stimulate collagen synthesis and improve skin elasticity. For hair loss, randomized trials show MSC therapy activates dormant follicles, increases density, and extends the anagen growth phase — with synergistic results when combined with PRP.
RCT — MSC + PRP for alopecia, Stem Cells Transl Med (2019) →
Review — MSC exosomes in skin rejuvenation, Dermatologic Surgery (2019) →
05
IV & Systemic Therapy
IV-administered MSC therapy has been studied for autoimmune conditions, post-surgical recovery, and systemic inflammation. Research demonstrates anti-inflammatory effects, immune regulation, and organ-protective properties from intravenous administration.
Review — IV MSC safety & efficacy, Cell Stem Cell (2017) →
Meta-analysis — MSC infusion for autoimmune disease, The Lancet (2019) →
From consultation to recovery — every step is evidence-based.
Our treatment methodology follows a structured, physician-led process designed to maximize therapeutic outcomes while maintaining the highest safety standards.
01
Clinical Assessment & Imaging Review
Your protocol begins with a comprehensive evaluation: medical history review, imaging analysis (MRI, X-ray, ultrasound), and a virtual consultation with your assigned specialist. We determine whether MSC therapy is appropriate for your specific condition and establish measurable treatment goals.
02
Cell Selection & Preparation
Based on your condition, our physician prescribes the optimal cell type, dosage, and delivery method. Innocell prepares your MSC batch — viability tested, sterility confirmed, and documented with full chain-of-custody traceability. Cells are delivered fresh to our clinic on the day of your procedure.
03
Image-Guided Administration
For orthopedic and spinal protocols, MSCs are delivered via ultrasound or fluoroscopy-guided injection — ensuring precise placement at the injury site. IV protocols use controlled infusion with real-time monitoring. Aesthetic protocols use targeted intradermal or subcutaneous injection techniques. Precision maximizes therapeutic impact.
04
Post-Treatment Monitoring
Immediately after treatment, you're monitored at our clinic. Your physician provides personalized recovery guidelines: activity restrictions, anti-inflammatory management, and expected timeline for improvements. Most patients can resume normal activities within 24–72 hours depending on the protocol.
05
Telemedicine Follow-Up
Your care continues after you leave Medellín. Scheduled telemedicine consultations at 2 weeks, 6 weeks, 3 months, and 6 months post-treatment allow us to track your progress, answer questions, and adjust your rehabilitation plan. You're never alone in your recovery.
06 — Safety & Quality
Your safety is non-negotiable.
Regenerative medicine demands rigorous standards at every stage. All MSCs are sourced from ethically obtained umbilical cord tissue from screened, healthy donors — tested for sterility, endotoxins, mycoplasma, and viability before release. Innocell's GMP-certified lab operates in ISO Class 7 clean rooms with full batch-level documentation.
Every treatment is prescribed and administered by a board-certified physician using image-guided delivery. Post-procedure monitoring and telemedicine follow-ups ensure any adverse events are caught early. Common side effects are mild and transient — localized swelling, minor bruising, and temporary discomfort.
- Donor screening: HIV, Hepatitis B & C, syphilis, CMV
- Cell batch testing: sterility, endotoxins, mycoplasma, viability (≥95%)
- ISO Class 7 clean room & GMP-certified processing
- Board-certified physicians with regenerative medicine training
- Active screening for contraindications (cancer, uncontrolled infection, pregnancy)
- Honest assessments — we decline patients who aren't good candidates
Questions about the science.
What are mesenchymal stem cells (MSCs)?
Mesenchymal stem cells are multipotent adult cells that can develop into bone, cartilage, muscle, and fat tissue. More importantly, they release powerful growth factors and anti-inflammatory signals that recruit your body's own repair mechanisms. Colombia Care uses MSCs sourced from ethically obtained umbilical cord tissue, processed in a GMP-certified laboratory.
Where do the stem cells come from?
Our MSCs are sourced from umbilical cord tissue (Wharton's jelly) — collected from healthy, screened donors after full-term pregnancies. This is one of the richest sources of young, potent mesenchymal stem cells. The tissue is ethically obtained with informed consent and would otherwise be discarded as medical waste.
Is stem cell therapy safe?
MSC therapy has a strong safety profile across hundreds of clinical trials worldwide. Common side effects are mild and temporary — localized swelling, minor bruising, and transient discomfort. Serious adverse events are extremely rare. Colombia Care's INVIMA regulation, GMP-certified cell processing, and physician-led protocols add multiple layers of safety assurance.
Is stem cell therapy legal in Colombia?
Yes. Colombia has a regulatory framework for regenerative medicine under INVIMA (Colombia's FDA equivalent). Unlike many countries that have not yet established clear regulatory pathways for stem cell therapy, Colombia provides a legal, regulated environment for MSC treatments — which is one of the reasons international patients choose Medellín for regenerative medicine.
How does Colombia's regulatory framework compare to the US?
In the US, the FDA classifies most stem cell therapies as investigational, meaning they're typically only available through clinical trials. Colombia's INVIMA permits MSC therapy under regulatory oversight — similar to how other countries like Japan, South Korea, and parts of the EU have established expedited regulatory pathways for regenerative therapies. This means you can access treatments in Colombia that may not yet be available through standard US medical channels.
What is GMP certification and why does it matter?
GMP (Good Manufacturing Practice) is the international standard for pharmaceutical and biological product manufacturing. Innocell's GMP certification means their cell processing follows validated protocols, uses calibrated equipment in clean-room environments, and maintains rigorous documentation. It's the same standard applied to drug manufacturing worldwide.
How many stem cells are used per treatment?
Cell dosage varies by condition, delivery method, and treatment goals. Typical protocols range from 20 million to 100+ million MSCs depending on whether the treatment is localized (joint injection) or systemic (IV infusion). Your physician determines the optimal dosage based on your clinical assessment and published dosing evidence.
How long do results last?
Results vary by condition and patient. Published studies on orthopedic MSC therapy report sustained improvements at 12–24+ months. Some patients opt for maintenance protocols annually. During your consultation, your physician will provide evidence-based expectations specific to your condition.
Explore our research articles.
Safety
INVIMA explained: what Colombia's FDA equivalent means for your safety
Understanding why INVIMA regulation sets Colombia apart for regenerative medicine.
Read article →
Orthopedic
Avoiding knee replacement: the case for regenerative orthopedics
How mesenchymal stem cells can delay or replace joint surgery for many patients.
Read article →